Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to ‘switching’ in bipolar disorder?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Psychiatry

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1038/mp.2008.117PMID 18982003PMCID PMC2874651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Administration of Lamotrigine Downregulates COX-2 mRNA and Protein in Rat Frontal Cortex

  2008cited by this paper
• Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat Published, JLR Papers in Press, October 23, 2007.

  2008cited by this paper
• Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.

  2008cited by this paper
• Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway.

  2008cited by this paper
• Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?

  2008cited by this paper
• Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.

  2007cited by this paper
• Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex

  2007cited by this paper
• n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism

  2007cited by this paper
• Chronic lamotrigine does not alter the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat: implications for the treatment of bipolar disorder

  2007cited by this paper
• Retracted: Chronic NMDA administration to rats up‐regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein‐2

  2007cited by this paper
• RETRACTED: Secretory phospholipase A2 IIA is up-regulated by TNF-α and IL-1α/β after transient focal cerebral ischemia in rat

  2007cited by this paper
• RETRACTED: Chronic administration of carbamazepine down-regulates AP-2 DNA-binding activity and AP-2alpha protein expression in rat frontal cortex.

  2007cited by this paper
• Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline

  2006cited by this paper
• Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

  2006cited by this paper
• Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.

  2006cited by this paper
• Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex

  2006cited by this paper
• Antidepressant drug induced alterations in binding to central dopamine transporter sites in the Wistar Kyoto rat strain.

  2006cited by this paper
• Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats.

  2006cited by this paper
• Chronic fluoxetine increases cytosolic phospholipase A2 activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat

  2006cited by this paper
• Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder.

  2006cited by this paper
• 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter

  2005cited by this paper
• Lipid signaling in neural plasticity, brain repair, and neuroprotection

  2005cited by this paper
• Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat

  2005cited by this paper
• Rapid High-Energy Microwave Fixation is Required to Determine the Anandamide (N-arachidonoylethanolamine) Concentration of Rat Brain

  2005cited by this paper
• 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.

  2005cited by this paper
• Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats

  2005cited by this paper
• Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramine

  2005cited by this paper
• Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors.

  2005cited by this paper
• Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl–CoA by brain microsomal long-chain fatty acyl–CoA synthetases: relevance to bipolar disorder

  2005cited by this paper
• Chronic Lithium Chloride Administration to Unanesthetized Rats Attenuates Brain Dopamine D2-Like Receptor-Initiated Signaling Via Arachidonic Acid

  2005cited by this paper
• Resolution of inflammation: the beginning programs the end

  2005cited by this paper
• Topiramate does not Alter the Kinetics of Arachidonic or Docosahexaenoic Acid in Brain Phospholipids of the Unanesthetized Rat

  2005cited by this paper
• Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism

  2005cited by this paper
• Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain.

  2004cited by this paper
• The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats

  2004cited by this paper
• The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.

  2004cited by this paper
• Calcium transients in astrocyte endfeet cause cerebrovascular constrictions

  2004cited by this paper
• A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

  2003cited by this paper
• Why is carbon from some polyunsaturates extensively recycled into lipid synthesis?

  2003cited by this paper
• Valproic acid down‐regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase‐1 and ‐2 in rat brain

  2003cited by this paper
• Effects of combined treatment with imipramine and metyrapone in the forced swimming test in rats. Behavioral and pharmacokinetic studies.

  2003cited by this paper
• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

  2003cited by this paper
• Antidepressants in bipolar disorder: the case for caution.

  2003cited by this paper
• Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology

  2003cited by this paper
• Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder

  2002cited by this paper
• Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain

  2002cited by this paper
• Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence.

  2002cited by this paper
• Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers

  2001cited by this paper
• Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Serine 727 Phosphorylation and Activation of Cytosolic Phospholipase A2 by MNK1-related Protein Kinases*

  2000cited by this paper
• Topiramate Monotherapy in the Maintenance Treatment of Bipolar I Disorder:Effects on Mood, Weight and Ser um Lipids

  2000cited by this paper
• Controlled trials in bipolar I depression: focus on switch rates and efficacy.

  1999cited by this paper
• Dynamics of Docosahexaenoic Acid Metabolism in the Central Nervous System: Lack of Effect of Chronic Lithium Treatment

  1999cited by this paper
• 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain.

  1999cited by this paper
• Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α

  1998cited by this paper
• Identification of the Phosphorylation Sites of Cytosolic Phospholipase A2 in Agonist-stimulated Human Platelets and HeLa Cells*

  1998cited by this paper
• Bipolar depression and antidepressant-induced mania: a naturalistic study.

  1998cited by this paper
• Interleukin-1β Stimulates Ovarian Phospholipase A2 (PLA2) Expression and Activity: Up-Regulation of Both Secretory and Cytosolic PLA21.

  1997cited by this paper
• Relation Between Free Fatty Acid and Acyl-CoA Concentrations in Rat Brain Following Decapitation

  1997cited by this paper
• Interleukin-1 beta stimulates ovarian phosphoipase A2 (PLA2) expression and activity: up-regulation of both secretory and cytosolic PLA2.

  1997cited by this paper
• Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells.

  1997cited by this paper
• Interleukin-1beta stimulates phospholipase A2 activity in adult rat ventricular myocytes.

  1997cited by this paper
• The PPARα–leukotriene B4 pathway to inflammation control

  1996cited by this paper
• The PPARalpha-leukotriene B4 pathway to inflammation control.

  1996cited by this paper
• Twice may be too many: redundant publications.

  1996cited by this paper
• Synaptic Effects of Antidepressants

  1996cited by this paper
• Lithium decreases turnover of arachidonate in several brain phospholipids.

  1996cited by this paper
• Specific Activity of Brain Palmitoyl‐CoA Pool Provides Rates of Incorporation of Palmitate in Brain Phospholipids in Awake Rats

  1995cited by this paper
• Structure of the human cyclo-oxygenase-2 gene.

  1994cited by this paper
• Brain Arachidonic Acid Incorporation and Precursor Pool Specific Activity During Intravenous Infusion of Unesterified [3H]Arachidonate in the Anesthetized Rat

  1994cited by this paper
• Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction.

  1994cited by this paper
• Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants.

  1994cited by this paper
• 5'-flanking region surrounding a human cytosolic phospholipase A2 gene.

  1994cited by this paper
• A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis.

  1992cited by this paper
• A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

  1991cited by this paper
• Phospholipid fatty acid remodeling in mammalian cells.

  1991cited by this paper
• Arachidonic Acid Cascade and Signal Transduction

  1990cited by this paper
• Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis.

  1990cited by this paper
• Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus.

  1990cited by this paper
• Intravenous injection of [1‐14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats

  1989cited by this paper
• Leukotrienes and lipoxins: structures, biosynthesis, and biological effects.

  1987cited by this paper
• Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.

  1986cited by this paper
• Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.

  1984cited by this paper
• A case of mania associated with fluoxetine.

  1984cited by this paper
• A case of mania associated with fluoxetine.

  1984cited by this paper
• Separation and quantitation of free fatty acids and fatty acid methyl esters by reverse phase high pressure liquid chromatography.

  1983cited by this paper
• Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages

  1981cited by this paper
• Extraction of tissue lipids with a solvent of low toxicity.

  1981cited by this paper
• Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group.

  1973cited by this paper
• Prostaglandin Receptor Site: Evidence for an Essential Role in the Action of Luteinizing Hormone

  1970cited by this paper
• Quantitative analysis of simple lipid classes by thin-layer chromatography.

  1968cited by this paper
• A simple method for the isolation and purification of total lipides from animal tissues.

  1957cited by this paper

• Polyunsaturated fatty acids as predictors of future suicide attempt.

  2021cites this paper
• Adjunctive dietary intervention for bipolar disorder: a randomized, controlled, parallel‐group, modified double‐blinded trial of a high n‐3 plus low n‐6 diet

  2021cites this paper
• Upregulation of the mGlu5 receptor and COX-2 protein in the mouse brain after imipramine and NS398, searching for mechanisms of regulation.

  2021cites this paper
• Indomethacin, a nonselective cyclooxygenase inhibitor, does not interact with MTEP in antidepressant-like activity, as opposed to imipramine in CD-1 mice.

  2020cites this paper
• NS398, a cyclooxygenase-2 inhibitor, reverses memory performance disrupted by imipramine in C57Bl/6J mice.

  2020cites this paper
• Are Polyunsaturated Fatty Acids Implicated in Histaminergic Dysregulation in Bipolar Disorder?: AN HYPOTHESIS

  2018cites this paper
• Pharmacological properties and innovative therapeutic targets of novel compounds used to treat major depression

  2018cites this paper
• Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa

  2017cites this paper
• University of Groningen Investigation of common , low-frequency and rare genome-wide variation in anorexia nervosa Kas

  2017cites this paper
• Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats.

  2016cites this paper
• IMMUNE SYSTEM ALTERATIONS AND EXCITATORY SYMPTOMS IN AFFECTIVE DISORDERS

  2016cites this paper
• Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.

  2016cites this paper
• Role of Dietary Fatty Acids in Mood Disorders

  2016cites this paper
• Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.

  2015cites this paper
• Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.

  2015cites this paper
• Reduced mRNA Expression of PTGDS in Peripheral Blood Mononuclear Cells of Rapid-Cycling Bipolar Disorder Patients Compared with Healthy Control Subjects

  2015cites this paper
• Neuroinflammation and excitatory symptoms in bipolar disorder

  2015cites this paper
• Place de la chirurgie bariatrique par sleeve gastrectomie chez le patient bipolaire obèse : nouvelles perspectives

  2015cites this paper
• Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade.

  2014cites this paper
• Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder.

  2014influential citation
• A genome‐wide linkage scan of bipolar disorder in Latino families identifies susceptibility loci at 8q24 and 14q32

  2014cites this paper
• Inflamed moods: a review of the interactions between inflammation and mood disorders.

  2014cites this paper
• The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model

  2014cites this paper
• Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function

  2013cites this paper
• Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability

  2013cites this paper
• Association of plasma ω-3 and ω-6 lipids with burden of disease measures in bipolar subjects.

  2012cites this paper
• Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?

  2012cites this paper
• Fats and Factors: Lipid Profiles Associate with Personality Factors and Suicidal History in Bipolar Subjects

  2012cites this paper
• Behavioral neurobiology of bipolar disorder and its treatment

  2011cites this paper
• Upregulated arachidonic acid signalling in the olfactory bulbectomized rat model of depression.

  2011cites this paper
• Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E2 concentration in rat brain

  2011cites this paper
• Potential novel therapeutics for bipolar disorders.

  2011cites this paper
• [Smoking in affective psychosis: review about nicotine use in bipolar and schizoaffective disorders].

  2011cites this paper
• Molecular pharmacology in a simple model system: Implicating MAP kinase and phosphoinositide signalling in bipolar disorder

  2011cites this paper
• Fumar en las psicosis afectivas: revisión sobre el consumo de nicotina en el trastorno bipolar y esquizoafectivo

  2011cites this paper
• Brain arachidonic acid uptake and turnover: implications for signaling and bipolar disorder

  2010cites this paper
• The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?

  2009cites this paper
• Is the brain arachidonic acid cascade a common target of drugs used to manage bipolar disorder?

  2009cites this paper
• Bipolar disorder and mechanisms of action of mood stabilizers.

  2009cites this paper